Keyphrases
Meta-analysis
100%
Systematic Meta-analysis
100%
Breast Cancer Patients
100%
Neoadjuvant Chemotherapy
100%
Confidence Interval
75%
Hazard Ratio
62%
Breast Reconstruction
50%
Locoregional Recurrence
37%
Cochrane
25%
Surgery Rates
25%
Disease-free Survival
25%
MEDLINE
12%
Overall Survival
12%
Randomized Controlled Trial
12%
Functional Outcome
12%
Risk Ratio
12%
Chemotherapy
12%
Random Effects
12%
Subgroup Analysis
12%
Breast Cancer Survival
12%
Tumor Size
12%
Fixed Effects
12%
Risk of Bias
12%
Recurrence Rate
12%
Risk of Bias Assessment
12%
Oncological Outcomes
12%
Distant Metastasis
12%
Preoperative Chemotherapy
12%
Preoperative Neoadjuvant Chemotherapy
12%
Complete Tumor Response
12%
Nursing and Health Professions
Breast Cancer
100%
Meta Analysis
100%
Systematic Review
100%
Neoadjuvant Chemotherapy
100%
Confidence Interval
66%
Hazard Ratio
55%
Partial Mastectomy
44%
Recurrent Disease
22%
Disease Free Survival
22%
Neoplasm
11%
Medline
11%
Overall Survival
11%
Recurrence Risk
11%
Cancer Survival
11%
Distant Metastasis
11%
Preoperative Chemotherapy
11%
Tumor Volume
11%
Medicine and Dentistry
Breast Cancer
100%
Meta-Analysis
100%
Systematic Review
100%
Neoadjuvant Chemotherapy
100%
Hazard Ratio
55%
Quadrantectomy
44%
Neoplasm
22%
Recurrent Disease
22%
Disease Free Survival
22%
Randomized Controlled Trial
11%
Overall Survival
11%
Recurrence Risk
11%
Breast Cancer Survival
11%
Distant Metastasis
11%
Preoperative Chemotherapy
11%
Chemotherapy
11%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Breast Cancer
100%
Neoplasm
18%
Recurrent Disease
18%
Disease Free Survival
18%
Randomized Controlled Trial
9%
Recurrence Risk
9%
Overall Survival
9%
Cancer Survival
9%
Distant Metastasis
9%
Immunology and Microbiology
Disease Free Survival
100%
Medline
50%
Overall Survival
50%
Tumor Volume
50%
Cancer Survival
50%